Suppr超能文献

用于评估器官特异性体内清除率的手术大鼠模型的建立与应用。

Establishment and use of surgical rat models for assessment of organ specific in vivo clearance.

作者信息

Vestergaard Bill

出版信息

Dan Med J. 2016 Jun;63(6).

Abstract

Knowledge of clearance plays a key role in the development of new drug entities, especially in the development of improved analogues for treatment of chronic conditions. Improved pharmacokinetic properties can be used to increase dosing interval and thereby improve patient compliance. This will lead to improved treatment outcome or decreased risk of treatment failure when treating chronic conditions. Therefore, animal models for assessment of organ-specific clearance are of great value in preclinical drug development. These models can be used to obtain insights into the relative importance of a clearance organ and thereby guide drug design of new analogues in early drug discovery. The current PhD project was undertaken to explore surgical in vivo models, which could be used in the assessment of the relative importance of major clearance organs. It was the aim of the PhD project to establish and validate both a nephrectomy model and a hepatectomy model as tools to investigate relative importance of renal and hepatic clearance. Furthermore, the project aim was to investigate renal clearance of rFVIIa and rhGH using a nephrectomy model in rats. The thesis is composed of a short theoretical background, a literature review, two papers based on experimental work as well as experimental work not included in the papers. Chapter one is an introduction with the specific aims and hypotheses. The chapters from two to five contain theoretical background of the clearance concept, anatomical and physiological description of clearance organs and a brief overview of potential clearance models including in vivo models. Chapters six through nine highlight the experimental work with the results obtained during the PhD project. Lastly, the chapters from ten to twelve contain a general discussion, conclusion and perspectives of the current thesis. Paper I "Nephrectomized and hepatectomized animal models as tools in preclinical pharmacokinetics" provides a literature review of animal models previously used as tools to investigate renal and hepatic clearance. An overview of the surgical procedures previously described for establishment of in vivo nephrectomy and hepatectomy models is given. Many different surgical methods have been employed in the attempt to make anephric or anhepatic in vivo models. The overall conclusion of the literature review was that a suitable clearance model would require only one surgical procedure. Furthermore, the clearance studies should be conducted immediately after completed surgery to decrease the impact on other clearance pathways and physiology in general. Paper II "The kidneys play an important role in the clearance of rFVIIa in rats" describes the establishment, validation and use of an in vivo model for assessment of renal clearance. The model employed was a rat nephrectomy model and the compounds investigated were inulin and rFVIIa. General physiology was assumed to be close to normal as rectal temperature, oxygen saturation and pulse were within normal range during the pharmacokinetic studies. Nephrectomy significantly reduced clearance of rFVIIa and almost completely abolished clearance of inulin. Thus, it was concluded that the nephrectomy model could be used in assessment of the relative importance of the kidneys in the clearance of rFVIIa and the data obtained indicate that renal clearance accounts for 50% of total body clearance of rFVIIa. Paper III "The kidneys play a central role in the clearance of rhGH in rats" addresses renal clearance of rhGH. The in vivo model established in Paper II was used in a pharmacokinetic study of rhGH to assess the relative importance of the kidneys in the clearance of rhGH. The conclusion drawn based on this study was that the kidneys account for 90% of total body clearance of rhGH in anaesthetized rats. Furthermore, it was noted that anaesthesia reduced clearance of rhGH by 36% compared to non-anaesthetized rats. In conclusion, establishment, validation and use of a rat nephrectomy model as a tool to investigate renal clearance was successful, but an in vivo rat model of hepatic clearance model was not successfully established.

摘要

清除率的相关知识在新型药物实体的研发中起着关键作用,尤其是在开发用于治疗慢性病的改良类似物时。改善药代动力学特性可用于延长给药间隔,从而提高患者的依从性。这将改善慢性病治疗的效果或降低治疗失败的风险。因此,用于评估器官特异性清除率的动物模型在临床前药物研发中具有重要价值。这些模型可用于深入了解清除器官的相对重要性,从而在药物发现早期指导新类似物的药物设计。当前的博士项目旨在探索可用于评估主要清除器官相对重要性的体内手术模型。该博士项目的目标是建立并验证肾切除术模型和肝切除术模型,作为研究肾清除率和肝清除率相对重要性的工具。此外,该项目的目标是使用大鼠肾切除术模型研究重组凝血因子VIIa(rFVIIa)和重组人生长激素(rhGH)的肾清除率。本论文由简短的理论背景、文献综述、两篇基于实验工作的论文以及未包含在论文中的实验工作组成。第一章是引言,阐述了具体目标和假设。第二章至第五章包含清除率概念的理论背景、清除器官的解剖学和生理学描述,以及包括体内模型在内的潜在清除模型的简要概述。第六章至第九章重点介绍了博士项目期间获得的实验工作及结果。最后,第十章至第十二章包含本论文的总体讨论、结论和展望。论文一《肾切除和肝切除动物模型在临床前药代动力学中的应用》对先前用于研究肾清除率和肝清除率的动物模型进行了文献综述。给出了先前描述的用于建立体内肾切除术和肝切除术模型的手术程序概述。为了建立无肾或无肝的体内模型,人们采用了许多不同的手术方法。文献综述的总体结论是,合适的清除模型仅需一种手术程序。此外,清除率研究应在手术完成后立即进行,以减少对其他清除途径和整体生理学的影响。论文二《肾脏在大鼠rFVIIa清除中起重要作用》描述了用于评估肾清除率的体内模型的建立、验证和应用。所采用的模型是大鼠肾切除术模型,研究的化合物是菊粉和rFVIIa。在药代动力学研究期间,由于直肠温度、血氧饱和度和脉搏均在正常范围内,因此假定总体生理学接近正常。肾切除术显著降低了rFVIIa的清除率,几乎完全消除了菊粉的清除率。因此,得出的结论是,肾切除术模型可用于评估肾脏在rFVIIa清除中的相对重要性,获得的数据表明肾清除率占rFVIIa全身清除率的50%。论文三《肾脏在大鼠rhGH清除中起核心作用》探讨了rhGH的肾清除率。在rhGH的药代动力学研究中,使用了论文二中建立的体内模型来评估肾脏在rhGH清除中的相对重要性。基于该研究得出的结论是,在麻醉大鼠中,肾脏占rhGH全身清除率的90%。此外,还注意到与未麻醉大鼠相比,麻醉使rhGH的清除率降低了36%。总之,成功建立、验证并应用了大鼠肾切除术模型作为研究肾清除率的工具,但未成功建立大鼠肝清除率的体内模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验